US venture Zentalis Pharmaceuticals, Inc. broke new ground when it raised around $190m in its successful Nasdaq IPO in early April after becoming the first company to hold an all-virtual roadshow and bell ringing ceremony on its trading debut.
It is now looking to break more ground outside the US with the establishment of a new joint venture in China that will take forward both in this market and globally three
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?